Contract 75N91019F00139
Leidos Biomedical Research Inc · Department Of Health And Human Services · September 24, 2020
Leidos Biomedical Research Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 24, 2020 for $84.39 million of work in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology). Performance is in Frederick, MD. This is a task or delivery order issued under parent IDIQ 75N91019D00024. The contract has been modified 7 times since the base award It uses cost-plus contract pricing. The most recent modification was on February 20, 2026. If all options are exercised, the contract could reach $163.47 million.
Contract details
- PIID
- 75N91019F00139
- Parent IDIQ
- 75N91019D00024
- Award type
- Delivery Order
- Pricing
- Cost Plus Fixed Fee
- Competition
- Full And Open Competition
- NAICS
- 541715 · Research And Development In The Physical, Engineering, And Life Sciences (Except Nanotechnology And Biotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Frederick, MD
- First action
- September 24, 2020
- Latest action
- February 20, 2026
Description
MD NET
Modification timeline
-
February 20, 2026Mod P00013 · Other Administrative Action$163.47M
-
November 25, 2025Mod P00012 · Other Administrative Action$163.47M
-
September 29, 2025Mod P00011 · Other Administrative Action$163.47M
-
August 16, 2024Mod P00009 · Other Administrative Action$121.55M
-
July 26, 2024Mod P00008 · Exercise An Option$121.55M
-
September 30, 2023Mod P00006 · Other Administrative Action$115.50M
-
September 27, 2023Mod P00005 · Exercise An Option$115.50M
-
September 24, 2020Mod P00003 · Funding Only ActionMODIFY LINE ITEM FOR OPTION YEAR 1: 03/04/2020 - 03/03/2021, AS FUNDS WERE INADVERTENTLY OMITTED$129.6K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $20.43M |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $327.13M |
| Lovelace Biomedical Research Institute | Department Of Health And Human Services | April 1, 2026 | $680.2K |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $8.00M |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $9.22M |
| The Emmes Company, Llc | Department Of Health And Human Services | April 1, 2026 | $771.5K |
Top contractors in NAICS 541715
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Fluor Marine Propulsion, Llc | 2 | $2.75B |
| 2 | California Institute Of Technology | 240 | $979.40M |
| 3 | The Johns Hopkins University Applied Physics Laboratory Llc | 204 | $482.74M |
| 4 | Lockheed Martin Corporation | 4 | $461.91M |
| 5 | Lockheed Martin Corp | 9 | $317.27M |
| 6 | The Aerospace Corporation | 85 | $308.18M |
| 7 | Fermi Forward Discovery Group, Llc | 1 | $289.92M |
| 8 | Lockheed Martin Corp | 7 | $285.45M |
| 9 | Amentum Technology, Inc. | 4 | $253.24M |
| 10 | The Mitre Corporation | 50 | $222.51M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N91019F00139?
Contract 75N91019F00139 is a federal contract awarded to Leidos Biomedical Research Inc by Department Of Health And Human Services on September 24, 2020 for $84.39 million of work classified under RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). It has been modified 7 times since the base award.
Who won contract 75N91019F00139?
Leidos Biomedical Research Inc won contract 75N91019F00139 from Department Of Health And Human Services.
How much is contract 75N91019F00139 worth?
Contract 75N91019F00139 has obligated $84.39 million to date, with a total potential value of $163.47 million if all options are exercised.